Document Detail

The amelioration of cardiac dysfunction after myocardial infarction by the injection of keratin biomaterials derived from human hair.
MedLine Citation:
PMID:  21885119     Owner:  NLM     Status:  Publisher    
Cardiac dysfunction following acute myocardial infarction is a major cause of advanced cardiomyopathy. Conventional pharmacological therapies rely on prompt reperfusion and prevention of repetitive maladaptive pathways. Keratin biomaterials can be manufactured in an autologous fashion and are effective in various models of tissue regeneration. However, its potential application in cardiac regeneration has not been tested. Keratin biomaterials were derived from human hair and its structure morphology, carryover of beneficial factors, biocompatibility with cardiomyocytes, and in vivo degradation profile were characterized. After delivery into infarcted rat hearts, the keratin scaffolds were efficiently infiltrated by cardiomyocytes and endothelial cells. Injection of keratin biomaterials promotes angiogenesis but does not exacerbate inflammation in the post-MI hearts. Compared to control-injected animals, keratin biomaterials-injected animals exhibited preservation of cardiac function and attenuation of adverse ventricular remodeling over the 8 week following time course. Tissue western blot analysis revealed up-regulation of beneficial factors (BMP4, NGF, TGF-beta) in the keratin-injected hearts. The salient functional benefits, the simplicity of manufacturing and the potentially autologous nature of this biomaterial provide impetus for further translation to the clinic.
Deliang Shen; Xiaofang Wang; Li Zhang; Xiaoyan Zhao; Jingyi Li; Ke Cheng; Jinying Zhang
Related Documents :
16679079 - Value of routine admission laboratory tests to predict thirty-day mortality in patients...
16762079 - Modular prevention of heart disease following acute coronary syndrome (acs) [isrctn4298...
1427939 - Asymptomatic coronary heart disease detected on epidemiological survey of urban populat...
21703479 - The crystalloid cardioplegia: advantages with a word of caution.
16906219 - Association of the t+294c polymorphism in ppar delta with low hdl cholesterol and coron...
11558839 - The 4g/5g promotor polymorphism of the plasminogen activator inhibitor-1 gene and late ...
15502719 - Noradrenaline use in the human donor and relationship with load-independent right ventr...
21487129 - Prognostic performance of low-dose coronary ct angiography with prospective ecg trigger...
7155949 - Left ventricular aneurysm in a child.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-8-31
Journal Detail:
Title:  Biomaterials     Volume:  -     ISSN:  1878-5905     ISO Abbreviation:  -     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-9-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8100316     Medline TA:  Biomaterials     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Department of Cardiology, First Affiliated Hospital, College of Medicine, Zhengzhou University, Zhengzhou, Henan 450052, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Induction of immunotolerance via mPEG grafting to allogeneic leukocytes.
Next Document:  Selective antileukemia effect of stabilized nanohybrid vesicles based on cholesteryl succinyl silane...